Yigao Ding - Search Results

Year	Number of Results
2002	3
2003	7
2004	10
2005	5
2006	2
2007	9
2008	13
2009	13
2010	12
2011	19
2012	25
2013	18
2014	19
2015	17
2016	18
2017	13
2018	15
2019	5
2020	1
2021	2
2022	4
2023	2
2024	1

1

Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.

Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, Luo O, Wang S, Wei J, Ding Y, Yu D. Li B, et al. Among authors: ding y. EBioMedicine. 2019 Jan;39:239-254. doi: 10.1016/j.ebiom.2018.11.063. Epub 2018 Dec 13. EBioMedicine. 2019. PMID: 30555042 Free PMC article.

2

PP2A-Mediated Anticancer Therapy.

Chen W, Wang Z, Jiang C, Ding Y. Chen W, et al. Among authors: ding y. Gastroenterol Res Pract. 2013;2013:675429. doi: 10.1155/2013/675429. Epub 2013 Nov 7. Gastroenterol Res Pract. 2013. PMID: 24307892 Free PMC article. Review.

3

FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury.

Ren H, Chen Y, Zhu Z, Xia J, Liu S, Hu Y, Qin X, Zhang L, Ding Y, Xia S, Wang J. Ren H, et al. Among authors: ding y. Cell Death Dis. 2023 Jun 17;14(6):367. doi: 10.1038/s41419-023-05879-w. Cell Death Dis. 2023. PMID: 37330523 Free PMC article.

4

Circulating microRNAs: potential biomarkers for cancer.

Yu DC, Li QG, Ding XW, Ding YT. Yu DC, et al. Int J Mol Sci. 2011;12(3):2055-63. doi: 10.3390/ijms12032055. Epub 2011 Mar 22. Int J Mol Sci. 2011. PMID: 21673939 Free PMC article. Review.

5

Risk assessment in patients undergoing liver resection.

Yu DC, Chen WB, Jiang CP, Ding YT. Yu DC, et al. Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):473-9. doi: 10.1016/s1499-3872(13)60075-2. Hepatobiliary Pancreat Dis Int. 2013. PMID: 24103276 Review.

6

Effect of chewing gum on the postoperative recovery of gastrointestinal function.

Ge W, Chen G, Ding YT. Ge W, et al. Int J Clin Exp Med. 2015 Aug 15;8(8):11936-42. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550107 Free PMC article. Review.

7

[Research progress in cell-based therapeutics of liver diseases].

Tan JJ, Ding YT. Tan JJ, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):312-5. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 22988554 Review. Chinese. No abstract available.

8

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.

Zhang L, Su K, Liu Q, Li B, Wang Y, Cheng C, Li Y, Xu C, Chen J, Wu H, Zhu M, Mai X, Cao Y, Peng J, Yue Y, Ding Y, Yu D. Zhang L, et al. Among authors: ding y. BMC Cancer. 2023 Nov 9;23(1):1081. doi: 10.1186/s12885-023-11601-y. BMC Cancer. 2023. PMID: 37946141 Free PMC article.

9

Bioartificial liver devices: Perspectives on the state of the art.

Ding YT, Shi XL. Ding YT, et al. Front Med. 2011 Mar;5(1):15-9. doi: 10.1007/s11684-010-0110-x. Epub 2010 Nov 19. Front Med. 2011. PMID: 21088931 Review.

10

The role of endothelial progenitor cells in tumour vasculogenesis.

Ding YT, Kumar S, Yu DC. Ding YT, et al. Pathobiology. 2008;75(5):265-73. doi: 10.1159/000151706. Epub 2008 Oct 15. Pathobiology. 2008. PMID: 18931528 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

216 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year